State Street Corp Gilead Sciences, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, State Street Corp holds 60,171,691 shares of GILD stock, worth $5.62 Billion. This represents 0.21% of its overall portfolio holdings.

Number of Shares

60,171,691

Previous 59,329,915 1.42%

Holding current value

$5.62 Billion

Previous $4.07 Billion 23.9%

% of portfolio

0.21%

Previous 0.18%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $56.1 Million - $70.7 Million	841,776 Added 1.42%	60,171,691 $5.04 Billion
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $103 Million - $118 Million	1,624,987 Added 2.82%	59,329,915 $4.07 Billion
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $131 Million - $160 Million	-1,831,497 Reduced 3.08%	57,704,928 $4.23 Billion
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $47.7 Million - $54.1 Million	651,378 Added 1.11%	59,536,425 $4.82 Billion
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $32 Million - $34.9 Million	-432,115 Reduced 0.73%	58,885,047 $4.41 Billion
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $115 Million - $131 Million	1,514,894 Added 2.62%	59,317,162 $4.57 Billion
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $88.1 Million - $100 Million	-1,139,105 Reduced 1.93%	57,802,268 $4.8 Billion
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $18.6 Million - $26.7 Million	-298,977 Reduced 0.5%	58,941,373 $5.06 Billion
Q3 2022 Nov 15, 2022	BUY	$59.54 - $68.01 $77 Million - $88 Million	1,293,414 Added 2.23%	59,240,350 $3.65 Billion
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $1.39 Million - $1.56 Million	-24,023 Reduced 0.04%	57,946,936 $3.58 Billion
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $34.8 Million - $43.7 Million	601,690 Added 1.05%	57,970,959 $3.45 Billion
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $142 Million - $161 Million	2,187,144 Added 3.96%	57,369,269 $4.17 Billion
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $59.7 Million - $64.4 Million	882,466 Added 1.63%	55,182,125 $3.85 Billion
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $52.7 Million - $57.6 Million	829,887 Added 1.55%	54,299,659 $3.74 Billion
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $104 Million - $119 Million	-1,736,787 Reduced 3.15%	53,469,772 $3.46 Billion
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $101 Million - $115 Million	-1,786,770 Reduced 3.14%	55,206,559 $3.22 Billion
Q3 2020 Nov 10, 2020	SELL	$62.1 - $78.08 $64.2 Million - $80.7 Million	-1,033,383 Reduced 1.78%	56,993,329 $3.6 Billion
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $88.4 Million - $103 Million	1,221,502 Added 2.15%	58,026,712 $4.46 Billion
Q1 2020 May 11, 2020	BUY	$62.63 - $80.22 $3.56 Billion - $4.56 Billion	56,805,210 New	56,805,210 $4.25 Billion

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Gilead Sciences, Inc. Transaction History